0 items USD 0.00Search
- Did you mean
- liposomal storage disease
Your search for "Lysosomal Storage Disease" gave back 85276 results.
Market Analysis and Insights: Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market The global Lysosomal Acid Lipase Deficiency (LALD)...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Lysosomal Alpha Glucosidase - Pipeline Review, H2 2020 Summary Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20...
Catalog:
Global Markets Direct
July 2020
Price: USD 3,500.00
The Sphingolipidoses are a group of inherited metabolic disorder caused due to deficiency of specific enzymes in the body. It is also known as...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022...
Catalog:
Global Markets Direct
July 2022
Price: USD 2,000.00
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,000.00
Lysosomal Storage Disorder (Metabolic Disorders) - Drugs in Development, 2021 Summary Lysosomal Storage Disorder (Metabolic Disorders) - Drugs in...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Lysosomal Storage Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Lysosomal Storage Disorder Drugs...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,500.00
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Metabolic Disorder Therapeutics market is projected to reach US$ 64560 million in 2029, increasing from US$ 46680 million in 2022, with...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Metabolic Disorders Therapeutics is a drug used to treat the symptoms of metabolic disorders caused by a variety of causes. The “Metabolic Disorders...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Metabolic Disorder Therapeutics Industry Forecast” looks at past sales and reviews total world Metabolic Disorder Therapeutics sales in 2022,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
N Sulphoglucosamine Sulphohydrolase - Pipeline Review, H2 2020 Summary N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or...
Catalog:
Global Markets Direct
August 2020
Price: USD 3,500.00
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Metabolic Disorders Therapeutics is a drug used to treat the symptoms of metabolic disorders caused by a variety of causes. Highlights The global...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
